BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35446161)

  • 41. Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Wu Z; Huang Q; Pu H; Qin J; Wang X; Ye K; Lu X
    Eur J Vasc Endovasc Surg; 2021 Jul; 62(1):65-73. PubMed ID: 34112574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.
    Cioppa A; Stabile E; Popusoi G; Salemme L; Cota L; Pucciarelli A; Ambrosini V; Sorropago G; Tesorio T; Agresta A; Biamino G; Rubino P
    Cardiovasc Revasc Med; 2012; 13(4):219-23. PubMed ID: 22632996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
    Mohapatra A; Saadeddin Z; Bertges DJ; Madigan MC; Al-Khoury GE; Makaroun MS; Eslami MH
    J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
    Shammas NW; Jones-Miller S; Shammas GA; Shammas WJ
    J Invasive Cardiol; 2020 Aug; 32(8):289-294. PubMed ID: 32737264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes mellitus and femoropopliteal in-stent restenosis.
    Voll F; Wolf F; Ingwersen M; Kinstner CM; Kufner S; Ibrahim T; Ott I; Krankenberg H; Fusaro M; Cassese S
    Vasa; 2022 Jul; 51(4):247-255. PubMed ID: 35543439
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
    Wei L; Guo J; Guo L; Qi L; Cui S; Tong Z; Hou P; Gu Y
    Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
    [No Abstract]   [Full Text] [Related]  

  • 49. Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.
    Shammas NW; Shammas GA; Arikat L; Shammas AN; Darrow A; Banerjee A; Rudy B
    J Invasive Cardiol; 2017 Jun; 29(6):207-208. PubMed ID: 28570235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application and value of excimer laser ablation in the treatment of lower limb atherosclerotic obliterans].
    Jiang XL; Ju S; Chen B; Jiang JH; Shi Y; Ma T; Lin CP; Guo DQ; Xu X; Dong ZH; Fu WG
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(14):1026-1030. PubMed ID: 33845542
    [No Abstract]   [Full Text] [Related]  

  • 51. Results of Excimer Laser Ablation Combined with Drug-Coated Balloon for Atherosclerotic Obliterans of Lower Extremity and Risk Factors for Loss of Primary Patency.
    Jiang X; Li X; Chen B; Jiang J; Shi Y; Ma T; Lin C; Guo D; Xu X; Ju S; Fu W; Dong Z
    Ann Vasc Surg; 2023 Apr; 91():223-232. PubMed ID: 36584966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.
    Shammas NW; Shammas GA; Jerin M
    J Endovasc Ther; 2013 Dec; 20(6):844-52. PubMed ID: 24325703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions.
    Yamaguchi K; Mori S; Fukagawa T; Kishida T; Nakano T; Shirai S; Mizusawa M; Makino K; Honda Y; Tsutsumi M; Kobayashi N; Yamawaki M; Ito Y
    Indian Heart J; 2023; 75(6):403-408. PubMed ID: 37739220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
    Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Auryon Laser in Peripheral Arterial Interventions: A Single-Center Experience (Auryon-SCE).
    Shammas NW; Shammas GA; Halupnik G; Fedele N; Comp K; Taleb EM; Jones-Miller S; Shammas AN; Shankarraman V
    J Invasive Cardiol; 2022 Jun; 34(6):E428-E432. PubMed ID: 35551106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Rocha-Singh KJ; Sachar R; DeRubertis BG; Nolte-Ernsting CCA; Winscott JG; Krishnan P; Scott EC; Garcia LA; Baeriswyl JL; Ansel G; Rosenfield K; Zeller T;
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):549-558. PubMed ID: 34080792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    Krishnan P; Farhan S; Schneider P; Kamran H; Iida O; Brodmann M; Micari A; Sachar R; Urasawa K; Scheinert D; Ando K; Tarricone A; Doros G; Tepe G; Yokoi H; Laird J; Zeller T
    J Am Coll Cardiol; 2022 Sep; 80(13):1241-1250. PubMed ID: 36137674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity.
    Jiang X; Ju S; Chen B; Jiang J; Shi Y; Ma T; Lin C; Xu X; Fu W; Dong Z
    J Endovasc Ther; 2023 Oct; 30(5):721-729. PubMed ID: 35514287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.